Latest news, press releases, and SEC filings for Centessa Pharmaceuticals PLC (CNTA) https://caymanjournal.com/stock/CNTA en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Tue, 28 Apr 2026 04:38:13 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 🧾 What This Document Is This is a **DEFA14A**, a type of SEC filing used for "definitive additional materials." Think of it as an official add-on to a main proxy statement. In this case, it's an **internal FAQ document** for Centessa Pharmaceuticals employees, explaining the company's acquisition https://caymanjournal.com/stock/CNTA/sec-filing/0001193125-26-134758 https://caymanjournal.com/stock/CNTA/sec-filing/0001193125-26-134758 Tue, 31 Mar 2026 00:00:00 GMT SEC Filing